tiprankstipranks
Navidea Biopharmaceuticals (NAVB)
NYSE MKT:NAVB

Navidea Financial Statements

275 Followers

Navidea Financial Overview

Navidea's market cap is currently ―. The company's EPS TTM is $-0.4; its P/E ratio is -0.61; Navidea is scheduled to report earnings on November 9, 2022, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 6.52K$ 0.00$ 50.35K$ 9.12K$ 13.06K
Gross Profit$ 6.05K$ 0.00$ 50.35K$ 9.12K$ 13.06K
EBIT$ -2.92M$ -2.98M$ -3.29M$ -2.42M$ -2.67M
EBITDA$ -2.90M$ -2.96M$ -3.27M$ -2.40M$ -2.65M
Net Income Common Stockholders$ -3.00M$ -2.99M$ -3.65M$ -2.44M$ -2.67M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 328.01K$ 1.22M$ 2.67M$ 3.72M$ 4.23M
Total Assets$ 2.50M$ 3.60M$ 6.64M$ 8.96M$ 11.28M
Total Debt$ 129.71K$ 332.40K$ 342.89K$ 471.96K$ 704.25K
Net Debt$ -198.30K$ -884.71K$ -2.33M$ -3.25M$ -3.53M
Total Liabilities$ 6.74M$ 5.71M$ 6.02M$ 4.83M$ 4.85M
Stockholders Equity$ 169.88K$ 1.32M$ 3.40M$ 4.28M$ 5.70M
Cash Flow
Free Cash Flow$ -2.26M$ -2.67M$ -2.82M$ -2.15M$ -2.45M
Operating Cash Flow$ -2.14M$ -2.56M$ -2.73M$ -2.01M$ -2.41M
Investing Cash Flow$ -121.19K$ -118.19K$ -89.44K$ -133.21K$ -39.30K
Financing Cash Flow$ 1.37M$ -339.45K$ -127.48K$ 2.21M$ 2.06M
Currency in USD

Navidea Earnings and Revenue History


Navidea Debt to Assets


Navidea Cash Flow


Navidea Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis